Predictors of adverse outcomes among patients with NAFLD, COVID-19

Predictors of adverse outcomes among patients with NAFLD, COVID-19

Researchers found certain diagnostics linked to adverse outcomes among patients with non-alcoholic fatty liver disease during COVID-19, according to a presentation at Digestive Disease Week.“COVID-19 has consistently shown in multiple studies to disproportionately affect those with metabolic syndrome-associated conditions. Although some smaller studies done during the pandemic reported an increased frequency of severe COVID-19 infection in patients with NAFLD, there is not much that is known in addition to this,” Sunny Sandhu, MD, internal medicine resident at the University ofRead More

Share on facebook
Share on twitter
Share on linkedin